No Data
No Data
Does This Valuation Of MeHow Innovative Ltd. (SZSE:301363) Imply Investors Are Overpaying?
Mei Hao Medical (301363.SZ): has repurchased 0.48% of the shares.
On September 2, Gleatcher announced that as of August 31, 2024, the company had repurchased a total of 1,968,851 shares of the company through a repurchase special securities account through centralized competitive bidding trading, accounting for 0.4842% of the total share capital. The highest fill price was 28.31 yuan/share and the lowest fill price was 22.80 yuan/share. The total transaction amount was 50,093,656.31 yuan (excluding transaction costs). This repurchase of shares is in compliance with the company's share repurchase plan and relevant laws and regulations.
MeiHao Medical (301363.SZ): Has signed a mass production order for insulin injection pens.
During recent investor relations activities, Meihao Medical (301363.SZ) stated that it has signed orders for the production of insulin injection pens, but its revenue proportion is currently small. The company's collaboration with related clients is steadily progressing, and delivery of orders is continuously developing in an orderly manner. At the same time, the company has two fully automated self-developed production lines in a pre-launch state.
Mehow Innovative: Summary of Half-Year Report in 2024.
Mehow Innovative: Half-year report for the year 2024.
Mei Hao Medical (301363.SZ): The net income in the first half of the year was 0.169 billion yuan, a year-on-year decrease of 29.78%.
On August 19th, Gelonhui reported the half-yearly report of Medtronic (301363.SZ) for 2024. During the reporting period, the total operating income was CNY 0.706 billion, a year-on-year decrease of 6.33%; the net income attributable to shareholders of the listed company was CNY 0.169 billion, a year-on-year decrease of 29.78%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was CNY 0.163 billion, a year-on-year decrease of 27.33%; and the basic earnings per share were CNY 0.42.
No Data
No Data